☆ 4.7 Editorial Material

Does a Diagnosis of Myelogenous Leukemia Require 20% Marrow Myeloblasts, and Does <5% MarrowMyeloblasts Represent a Remission? The History and Ambiguity of Arbitrary Diagnostic Boundaries in the Understanding of Myelodysplasia

ONCOLOGIST (2013)

Get Full Text
Add to Collection

Journal

ONCOLOGIST
Volume 18, Issue 9, Pages 973-980

Publisher

ALPHAMED PRESS
DOI: 10.1634/theoncologist.2013-0099

Keywords

Classification; Leukemic myeloblasts; Myelodysplasia; Myelogenous leukemia; Neoplasia; Refractory anemia; Clonal evolution

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.